TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07560618: Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Sponsor: Integrative Skin Science and Research · Phase: PHASE4 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 40 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$6,604,800

Rescue Site Savings

+$4,355,040

Unlock Full NCT07560618 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07560618 Rescue Dossier →